CD4 and non-small cell lung carcinoma: These findings suggest that CD4+ T cells play a crucial role in the biology of NSCLC BM and potentially contribute to differences in metastatic patterns, as oligo-synchronous BM shows a more significant alteration in the CD4+ T cell immune profile, both locally at the tumor site and systemically.